Eagle Asset Management Inc Myriad Genetics Inc Transaction History

Eagle Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$18.21 - $27.88 $174,378 - $266,978	-9,576 Reduced 2.65%	351,164 $6.7 Million
Q2 2022 Aug 10, 2022	SELL	$16.45 - $25.88 $401,100 - $631,032	-24,383 Reduced 6.33%	360,740 $6.55 Million
Q1 2022 May 12, 2022	BUY	$22.67 - $28.01 $427,873 - $528,660	18,874 Added 5.15%	385,123 $9.71 Million
Q4 2021 Feb 11, 2022	SELL	$24.13 - $32.63 $340,836 - $460,898	-14,125 Reduced 3.71%	366,249 $10.1 Million
Q3 2021 Nov 10, 2021	BUY	$29.97 - $36.66 $961,827 - $1.18 Million	32,093 Added 9.21%	380,374 $12.3 Million
Q2 2021 Aug 11, 2021	BUY	$25.39 - $32.61 $8.84 Million - $11.4 Million	348,281 New	348,281 $10.7 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.